---
schema_version: "secwatch.filing_event.v1"
accession: "0001193805-26-000696"
form_type: "8-K"
ticker: "IMUX"
cik: "0001280776"
company_name: "IMMUNIC, INC."
filed_at: "2026-05-27T11:00:48+00:00"
generated_at: "2026-05-27T11:07:31.023411+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Immunic appoints Erik Lundgren as CEO; Daniel Vitt resigns as CEO but remains on board

## Summary
- Erik Lundgren appointed CEO effective June 1, 2026; previously SVP at Genentech/Roche, led Ocrevus launch.
- Daniel Vitt resigns as CEO but retains board seat and responsibility for scientific strategy.
- Lundgren receives base salary $685K, target bonus 60%, and initial option for 1M shares under inducement plan.
- Phase 3 ENSURE trial in relapsing MS expected data readout by year-end 2026; Lundgren to lead toward potential NDA and commercialization.

## SEC filing metadata
- accession: 0001193805-26-000696
- form_type: 8-K
- ticker: IMUX
- cik: 0001280776
- company_name: IMMUNIC, INC.
- filed_at: 2026-05-27T11:00:48+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1280776/000119380526000696/0001193805-26-000696-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1280776/000119380526000696/e665513_8k-immunic.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193805-26-000696
- JSON: https://secwatch.observer/filing/0001193805-26-000696.json
- Plain text: https://secwatch.observer/filing/0001193805-26-000696.txt

## Source-grounded claims
- claim_id: 974f1a6bfc
  claim: Erik Lundgren was appointed as Chief Executive Officer at IMMUNIC, INC..
  evidence_excerpt: On May 22, 2026 (the “Effective Date”), Immunic, Inc. (the "Company") appointed Erik Lundgren, as Chief Executive Officer of the Company, with his start of employment beginning on June 1, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1280776/000119380526000696/0001193805-26-000696-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.